Get started
UNITEDHEALTH GROUPUNITEDHEALTH GROUPUNITEDHEALTH GROUP

UNITEDHEALTH GROUP

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

4UNH trade ideas

Cash printing machine on saleFor all the hatred UNH gets, this company is looking like a buy after this huge sell off. We are approaching the golden ratio around $380. The company generates $100bn in revenue per quarter, hence why it’s a highly regarded cash printing machine. The bearishness may continue as we sit below the 200week MA. I have a worst case scenario of $300 where we have a strong weekly level of support. I think we’ll bottom closer to the mid $300s so I’ll be taking a nibble with a longer term view on this stock. Not financial advice
NYSE:UNHLong
by NoFOMO_
$UNH Rinse & Repeat Round #2- Fundamentally it's undervalued for the quality blue chip company. My detailed analysis is on the older post I made earlier this year. I have attached that as a reference. - In my previous swing, I bought NYSE:UNH on a sell off @ 441 and sold @600 before earning as a de-risking strategy. I'm glad that it did work out. - I'm happy that NYSE:UNH is again trading at a discount and with compressed Earning multiple. This time I am buying it even lower than where I bought last time i.e 441 and I was happy with that price average. - Whereas I do believe that NYSE:UNH EPS is lowered but it is lowered slightly which doesn't warrant a big sell off like this. - I wanted to wait further before entering but I can't stop myself from buying this name NYSE:UNH at a price where I believe it's very undervalued. - Therefore, I have re-entered the NYSE:UNH and added it to my portfolio . I will consider adding further if selling pressure continues because I don't want to time the bottom. - But undecisive market and lumpy market, going with a defensive name like this is a no brainer.
NYSE:UNHLong
by bigbull037
UNH Under Pressure – Below EMA 200 with Heavy Selling VolumeUNH (UnitedHealth) is showing clear bearish signs: Price has dropped below the EMA 200, a key long-term support level Recent sessions show strong selling volume, indicating institutional exit Trend is downward, with no bullish confirmation yet ⚠️ I stay cautious here — waiting for volume shift or price reclaim above EMA before considering a reversal. Until then, the bearish momentum stays active. Not financial advice – just my technical view. #UNH #StockAnalysis #BearishTrend #VolumeAnalysis #EMA200 #TechnicalTrading #HealthcareStocks
NYSE:UNH
by abdeljalillariam
UnitedHealth (UNH) Share Price PlummetsUnitedHealth (UNH) Share Price Plummets UnitedHealth shares crashed by nearly 23% yesterday after the healthcare giant reported weaker-than-expected Q1 2025 results: → Earnings per share: actual = $7.20, expected = $7.29 → Revenue: actual = $109.5bn, expected = $111.5bn Technical Analysis of UNH Share Chart As far back as a year ago, we highlighted key support around the $450 level. Yesterday’s negative news caused this support to once again demonstrate its strength by holding back further decline — but will it hold? Taking the price action marked on the chart as a base, we can establish the structure of a descending channel (shown in red), with the price gapping sharply lower into the bottom half of this channel — and yesterday’s candle high (marked with an arrow) suggests that the median line has turned into resistance. Yesterday’s candle closed near its lows, so it is reasonable to assume that bearish pressure may persist (with the aim of testing the lower boundary) — in which case, the $450 support zone, in place since early 2022, could be at risk. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NYSE:UNH
by FXOpen
1
$UNH buy the fear or sell into narrative?- NYSE:UNH has gotten into trouble with bad headlines after bad headlines. - Recent DOJ probe led to 12% shaving in the stock price. - Could it be a buying opportunity or just a falling knife? - Are you afraid that NYSE:UNH could become NYSE:HUM 2.0? Let's talk about fundamentals! Year | 2024 | 2025 | 2026 | 2027 | 2028 GAAP EPS | 15.76. | 28.22 | 32.11 | 36.80 | 41.11 EPS growth% | -33.47% | 79.08% | 13.77% | 14.61% | 11.71% It appears that 2024/ Early 2025 was the year when EPS growth bottomed and would go from negative to positive back again. EPS growth is healthy double digit in mid teens. A fair forward p/e multiple for mid teen EPS growth should at least be 15 ( conservatively ) Year | 2024 | 2025 | 2026 | 2027 | 2028 Fair Stock Price (w/ forward p/e = 15 ) | $236 | $423 | $481 | $552 | $616 However, NYSE:UNH is a blue chip company and has a moat. Therefore, Investors will be willing to pay forward p/e of 20 once negative news subside. Year | 2024 | 2025 | 2026 | 2027 | 2028 Fair Stock Price (w/ forward p/e = 20 ) | $315 | $564 | $642 | $736 | $822.2 Final Take: I'm a buyer of NYSE:UNH < 450 will add more if it dips below 400 for the long term. Good quality companies don't usually buyers to get their skin into the game. Therefore, it's better to buy the fear than selling into narrative.
NYSE:UNHLong
by bigbull037
5
$UNH: UnitedHealth Group – Healthcare Hero or Reform Risk?(1/9) Good evening, everyone! 🌙 NYSE:UNH : UnitedHealth Group – Healthcare Hero or Reform Risk? With UNH at $505.69, post-7% drop, is this healthcare giant a safe bet or a reform casualty? Let’s diagnose! 🔍 (2/9) – PRICE PERFORMANCE 📊 • Current Price: $ 505.69 as of Mar 18, 2025 💰 • Recent Move: Stable after 7% drop, per user data 📏 • Sector Trend: Healthcare sector mixed with reforms and economic factors 🌟 It’s a steady pulse—let’s see if it’s time to buy or hold! ⚙️ (3/9) – MARKET POSITION 📈 • Market Cap: Approx $465B (920M shares) 🏆 • Operations: Health insurance and services across the U.S. ⏰ • Trend: Leading player with strong fundamentals, per data 🎯 Firm in healthcare, but reforms keep it on its toes! 🏥 (4/9) – KEY DEVELOPMENTS 🔑 • Mixed News: Healthcare reforms debated, earnings reports mixed, per user data 🌍 • Q4 2024 Earnings: Assume beat or miss based on context, per data 📋 • Market Reaction: Stabilized after drop, showing resilience 💡 Navigating through choppy waters! 🛳️ (5/9) – RISKS IN FOCUS ⚡ • Healthcare Reforms: Regulatory changes could impact business 🔍 • Competition: Other insurers and providers in the market 📉 • Economic Slowdown: Reduced consumer spending on healthcare ❄️ It’s a risky prescription—watch the side effects! 🛑 (6/9) – SWOT: STRENGTHS 💪 • Market Leader: Dominant in U.S. healthcare 🥇 • Diversified Portfolio: Insurance and services balance risk 📊 • Financial Strength: Strong earnings and cash flow, per data 🔧 Got the muscle to handle challenges! 🏦 (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES ⚖️ • Weaknesses: Regulatory scrutiny, high debt (if any) 📉 • Opportunities: Aging population, tech advancements in healthcare, per data 📈 Can it capitalize on growth or stumble on weaknesses? 🤔 (8/9) – POLL TIME! 📢 UNH at $505.69—your take? 🗳️ • Bullish: $600+ soon, reforms are manageable 🐂 • Neutral: Steady, risks balance out ⚖️ • Bearish: $450 looms, reforms hit hard 🐻 Chime in below! 👇 (9/9) – FINAL TAKEAWAY 🎯 UNH’s $505.69 price reflects stability after a drop, with mixed news and reforms in play 📈. DCA-on-dips could be a strategy to manage volatility. Gem or bust?
NYSE:UNHLong
by DCAChampion
$UNH - WHOLESALE/BUYING OPPORTUNITYUnitedHealth Group: A Leader in Healthcare Services UnitedHealth Group is a healthcare giant that provides a wide range of services, from health insurance to data consultancy. Let's break down its four main segments: UnitedHealthcare: Focuses on improving patient care, affordability, and effectiveness through Optum's capabilities. OptumHealth: Offers health and wellness care services to payers, care providers, employers, government, life sciences companies, and consumers. OptumInsight: Provides data and analytics, technology, and information to major healthcare industry participants. OptumRx: Offers pharmacy care services. A Commitment to Innovation UnitedHealth Group was founded in 1977 by Richard T. Burke and has since grown to become a global leader in healthcare services. With a focus on innovation and improvement, the company continues to shape the healthcare landscape. What do you think are the most important aspects of healthcare services? Share your thoughts in the comments!
NYSE:UNHLong
by ImmaculateTony
The Ugly Truth of Technical Analysis...Even though this may be an extremely unpopular opinion on this topic, realizing this simple truth may be what makes or breaks a profitable trader. The truth is this... Drawing lines on a chart does not predict any price movement, and there are more factors in play than simply price action It doesn't matter what the gurus on the internet say about some "secret strategy" or a "secret indicator", anyone with common sense should automatically ignore content like that. Firms like NYSE:JPM , NYSE:GS , NYSE:MS , etc. , spend billions upon billions of dollars just to figure out how to trade the market with efficiency, but some random 19 year old on the internet figured out how to beat these mega-firms with a free indicator. Yeah right. However, I'm not saying that technical analysis doesn't work or that it shouldn't be used; I'm simply saying to reconsider your strategy and use common sense before donating your money to Wall Street banks. Below is an example of technical analysis working perfectly on NYSE:UNH for the 1D timeframe looking back into April of last year. This would have been a textbook channel breakout trade, in which the trader takes a short when the bottom trendline is broken (or the candle closes below the trendline). It would have resulted in a maximum of 17% gain on naked short shares if the bottom penny is the exit price (which is virtually impossible). So there you have it... technical analysis works perfectly and I have proven myself wrong.... right? No. . Now let me show you what really happened. Here is the same exact chart, but this time with a piece of key information shown. As it turns out, there was nothing technical in play at all in this price action, but rather a "fundamental" or a "tangible" aspect was the price driver. An example like this should also show you that not providing sufficient information and taking charts out of context can be done by literally anyone. If you think you can predict the future with some geometric shapes, bars, and non financial, fundamental, or tangible analysis, better than the top Wall Street firms, I say good luck to you. WITH THAT BEING SAID, this does not mean that trendlines, price areas, value gaps, and other technical indicators are completely invalid, but it does mean that there is more to the story than what is on the chart. Always review news, sentiment, financials, analyst ratings, and other key oscillators to gauge every trade. Disclaimer: The indicators used on the chart are only for illustrative purposes of a cluttered chart. I am neither saying that they are accurate nor inaccurate.
NYSE:UNH
by addatheriver0808
UNH Stock Analysis: Potential Reversal Zone in a Downward ImpulsNYSE:UNH (UnitedHealth Group) appears to be in a downward impulsive wave, currently within the fifth wave. I anticipate a potential bounce near the blue horizontal line, which could act as a key support level. This analysis highlights a possible reversal zone, but keep in mind that this is not financial advice or a recommendation to buy or sell. Always monitor price action and volume closely to confirm any movement. #UNH #StockAnalysis #TechnicalAnalysis #TradingView #StockMarket #ElliottWave #SwingTrading
NYSE:UNHShort
by omossa